I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the research and development of pharmaceuticals and medical technologies; cell banking business; and contract manufacturing of products that applies medical technology to cosmetics, etc. It also supports medical institutions in conducting clinical trials; provides substitution and support for the work of pharmaceutical companies and academia that are involved in clinical research, including clinical trials of pharmaceuticals, medical devices, regenerative medicine, and other products; and operates clinic malls and other facilities. The company was formerly known as I'Rom Holdings Co., Ltd. and changed its name to I'rom Group Co., Ltd. in July 2015. I'rom Group Co., Ltd. was incorporated in 1997 and is headquartered in Tokyo, Japan.
Frequently asked questions
What sector does I’rom Holdings Co Ltd (2372) operate in?
I’rom Holdings Co Ltd belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is I’rom Holdings Co Ltd (2372) current stock price?
As of the latest data, I’rom Holdings Co Ltd stock price is ¥1,000,000, with a previous close of ¥1,000,000.
What is I’rom Holdings Co Ltd (2372) current market capitalization?
I’rom Holdings Co Ltd market cap is approximately 12.11 trillion.
Does I’rom Holdings Co Ltd (2372) pay dividends?
No. I’rom Holdings Co Ltd does not pay a dividend.
What is I’rom Holdings Co Ltd (2372) beta (volatility) score?
I’rom Holdings Co Ltd has a beta of 0.399, indicating lower volatility than the overall market.
